Deep Breathing Exercise for Pain and Hemodynamic Stability in Patients After Peripheral Percutaneous Angioplasty
Effectiveness of Deep Breathing Exercise on Pain and Hemodynamic Parameters in Patients After Peripheral Percutaneous Transluminal Angioplasty: A Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This randomized controlled trial evaluates the effectiveness of diaphragmatic deep breathing exercises on pain and hemodynamic parameters in patients after peripheral percutaneous transluminal angioplasty (PTA). Participants were randomly assigned to an intervention group, which performed the breathing exercises, or a control group, which received standard post-PTA care. Pain levels and hemodynamic parameters, including heart rate, blood pressure, and oxygen saturation, were measured before and after the intervention. Socio-demographic and clinical characteristics were also collected to explore potential associations with patient responses. The purpose of this study is to determine whether diaphragmatic deep breathing can reduce post-PTA pain and support hemodynamic stability, thereby improving patient comfort and recovery outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2026
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedMarch 11, 2026
March 1, 2026
2 months
March 2, 2026
March 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain intensity after diaphragmatic deep breathing exercises
Pain intensity measured using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst possible pain).
Before exercise, immediately after exercise, and one hour post-exercise
Secondary Outcomes (4)
systolic BP
Before exercise, immediately after exercise, and one hour post-exercise
Diastolic Blood Pressure
Before exercise, immediately after exercise, and one hour post-exercise
Heart Rate
Before exercise, immediately after exercise, and one hour post-exercise
Oxygen Saturation (SpO2)
Before exercise, immediately after exercise, and one hour post-exercise
Study Arms (2)
Intervention Group - Diaphragmatic Deep Breathing Exercises.
EXPERIMENTALPatients perform structured diaphragmatic deep breathing exercises after peripheral PTA. Pain is assessed using the Numeric Rating Scale (NRS), and hemodynamic parameters including heart rate, systolic and diastolic blood pressure, and oxygen saturation (SpO₂) are measured before, immediately after, and one hour post-exercise.
Control Group - Standard Post-PTA Care
NO INTERVENTIONPatients receive routine post-PTA care without diaphragmatic breathing exercises. Pain and hemodynamic parameters (HR, SBP, DBP, SpO₂) are measured at the same time points as the intervention group for comparison.
Interventions
Participants will perform guided diaphragmatic deep breathing exercises after peripheral percutaneous transluminal angioplasty (PTA). The technique involves slow deep inhalation through the nose with abdominal expansion followed by controlled exhalation through the mouth under researcher supervision. The intervention aims to reduce pain intensity and stabilize hemodynamic parameters.
Eligibility Criteria
You may qualify if:
- Aged 18 years and older.
- Patients diagnosed with peripheral arterial disease (PAD) and scheduled for peripheral percutaneous transluminal angioplasty (PTA).
- Patients able to communicate effectively and understand instructions.
- Patients who agree to participate and provide written informed consent.
You may not qualify if:
- Hemodynamically unstable patients
- Patients with psychiatric disorders or cognitive impairment affecting communication
- Pregnant patients
- Patients with severe respiratory diseases that interfere with breathing exercises
- Patients receiving opioid analgesics (e.g., pethidine) immediately after the procedure that may influence pain perception or hemodynamic parameters
- Patients with conditions affecting pain perception (e.g., diabetic peripheral neuropathy) or those receiving chronic analgesic therapy that may alter pain assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kufa Universitylead
Study Sites (1)
Najaf Center for Cardiac Surgery and Cardiac Catheterisation , Najaf Health Directorate
Najaf, Iraq
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Not applicable; all participants, care providers, and investigators were aware of group assignments.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master's Student (Adult Nursing) / Principal Investigator
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 11, 2026
Study Start
November 25, 2025
Primary Completion
January 25, 2026
Study Completion
January 25, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared to protect patient privacy and confidentiality. The study involves sensitive health information, and data sharing is restricted in accordance with institutional regulations and ethical approvals. Aggregate study results will be published without disclosing any identifiable participant information.